Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Journal of Pharmacy Practice
|
January 2, 2023
Adverse Drug Reaction vs Care Complication: Response to "Use of Colony-Stimulating Factors in Patients With Systemic Lupus Erythematous"
Carolyn E Ragsdale, Edwin P Rock
Frontiers in Immunology
|
February 24, 2023
Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis
Ila Joshi, Walter P Carney, Edwin P Rock
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
GCP data quality for early clinical development
Edwin P Rock, Vernette J Molloy, Jeffrey S Humphrey
Journal of Neuro-Oncology
|
March 28, 2012
Refining endpoints in brain tumor clinical trials
Christina A Meyers, Edwin P Rock, Howard A Fine
Cureus
|
July 10, 2024
Selectins in Biology and Human Disease: Opportunity in E-selectin Antagonism
John M Peterson, Theodore A Smith, Edwin P Rock, et al.
Journal of the National Cancer Institute. Monographs
|
October 24, 2007
Challenges to use of health-related quality of life for Food and Drug Administration approval of anticancer products
Edwin P Rock, Jane A Scott, Dianne L Kennedy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2007
Patient-reported outcomes supporting anticancer product approvals
Edwin P Rock, Dianne L Kennedy, Melissa H Furness, et al.
Journal for Immunotherapy of Cancer
|
January 7, 2022
Role of Fcγ receptors in HER2-targeted breast cancer therapy
Antonino Musolino, William J Gradishar, Hope S Rugo, et al.
The Oncologist
|
January 18, 2007
Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma
Edwin P Rock, Vicki Goodman, Janet X Jiang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 13, 2007
Patient-reported outcomes to support medical product labeling claims: FDA perspective
Donald L Patrick, Laurie B Burke, John H Powers, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Journal of Pharmacy Practice
|
January 2, 2023
Adverse Drug Reaction vs Care Complication: Response to "Use of Colony-Stimulating Factors in Patients With Systemic Lupus Erythematous"
Carolyn E Ragsdale, Edwin P Rock
Frontiers in Immunology
|
February 24, 2023
Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis
Ila Joshi, Walter P Carney, Edwin P Rock
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
GCP data quality for early clinical development
Edwin P Rock, Vernette J Molloy, Jeffrey S Humphrey
Journal of Neuro-Oncology
|
March 28, 2012
Refining endpoints in brain tumor clinical trials
Christina A Meyers, Edwin P Rock, Howard A Fine
Cureus
|
July 10, 2024
Selectins in Biology and Human Disease: Opportunity in E-selectin Antagonism
John M Peterson, Theodore A Smith, Edwin P Rock, et al.
Journal of the National Cancer Institute. Monographs
|
October 24, 2007
Challenges to use of health-related quality of life for Food and Drug Administration approval of anticancer products
Edwin P Rock, Jane A Scott, Dianne L Kennedy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2007
Patient-reported outcomes supporting anticancer product approvals
Edwin P Rock, Dianne L Kennedy, Melissa H Furness, et al.
Journal for Immunotherapy of Cancer
|
January 7, 2022
Role of Fcγ receptors in HER2-targeted breast cancer therapy
Antonino Musolino, William J Gradishar, Hope S Rugo, et al.
The Oncologist
|
January 18, 2007
Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma
Edwin P Rock, Vicki Goodman, Janet X Jiang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 13, 2007
Patient-reported outcomes to support medical product labeling claims: FDA perspective
Donald L Patrick, Laurie B Burke, John H Powers, et al.
Page
of 2